Last reviewed · How we verify
NCT06578988
Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEtting
trial testing Mammography Images in Cancer, Breast in 25,000 participants. Status unknown.
1 April 2025
Quick facts
| Lead sponsor | Royal Marsden NHS Foundation Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 25,000 |
| Start date | 1 March 2024 |
| Primary completion | 1 April 2025 |
| Estimated completion | 1 October 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Mammography Images
Conditions studied
- Cancer, Breast — all drugs for Cancer, Breast →
Sponsor
Royal Marsden NHS Foundation Trust
Who can join
18 and older, any sex, with Cancer, Breast. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Artificial Intelligence (AI) systems for the classification of mammography images have been developed and are beginning to be trialled and deployed in a breast cancer screening setting with encouraging results. It is reasonable to think that these systems could be useful in the context of symptomatic breast clinic. However, these systems developed in the screening setting have unknown performance in the context of symptomatic breast clinic. It is therefore important to test the performance of these systems in this alternative context. This study will use retrospective data, from where it is possible to determine ground truth outcomes with greater confidence, accessing relatively large volumes of data with less patient burden when compared to prospective studies. This important cohort of patients has been less investigated to date, mainly because symptomatic data is typically more difficult to curate than screening data where key data is methodically prospectively collected. The proposed work will be carried out in collaboration with a selected AI vendor and local clinical teams to define optimal use case scenarios for the symptomatic breast clinic.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06578988
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer, Breast
Currently open trials in the same condition.
- NCT06672120 — Exercise in Triple- Negative Breast Cancer · NA · recruiting
- NCT06345534 — FAST-FORWARD vs HAI5 · NA · recruiting
- NCT05721976 — With Love, Grandma ("Con Cariño, Abuelita") Pilot Study · NA · recruiting
- NCT04258813 — Onco-primary Care Networking to Support TEAM-based Care · NA · active not recruiting
- NCT05289258 — Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments · NA · recruiting
Other Royal Marsden NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07407686 — Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services · not yet recruiting
- NCT07243834 — Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise · NA · recruiting
- NCT06605833 — CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma · enrolling by invitation
- NCT07008742 — Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Canc · recruiting
- NCT06560905 — Preoperative Planning With PSMA-PET in Melanoma Surgery Trial · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06578988 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Royal Marsden NHS Foundation Trust
- Last refreshed: 30 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06578988.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing